159 related articles for article (PubMed ID: 2635738)
1. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver.
Xu X; Pang KS
J Pharmacokinet Biopharm; 1989 Dec; 17(6):645-71. PubMed ID: 2635738
[TBL] [Abstract][Full Text] [Related]
2. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
Xu X; Tang BK; Pang KS
J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
[TBL] [Abstract][Full Text] [Related]
3. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.
Morris ME; Yuen V; Tang BK; Pang KS
J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309
[TBL] [Abstract][Full Text] [Related]
4. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
Tirona RG; Pang KS
Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815
[TBL] [Abstract][Full Text] [Related]
5. Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver.
Morris ME; Yuen V; Pang KS
J Pharmacokinet Biopharm; 1988 Dec; 16(6):633-56. PubMed ID: 3251033
[TBL] [Abstract][Full Text] [Related]
6. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Hirayama H; Pang KS
Drug Metab Dispos; 1990; 18(5):580-7. PubMed ID: 1981705
[TBL] [Abstract][Full Text] [Related]
7. Estimations of intestinal and liver first-pass metabolism in vivo. Studies on gentisamide conjugation in the rat.
Hirayama H; Morgado J; Gasinska I; Pang KS
Drug Metab Dispos; 1990; 18(5):588-94. PubMed ID: 1981706
[TBL] [Abstract][Full Text] [Related]
8. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Xu X; Hirayama H; Pang KS
Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500
[TBL] [Abstract][Full Text] [Related]
9. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.
Xu X; Selick P; Pang KS
J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683
[TBL] [Abstract][Full Text] [Related]
10. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
Pang KS; Barker F; Schwab AJ; Goresky CA
J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
[TBL] [Abstract][Full Text] [Related]
12. Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.
Morris ME; Pang KS
J Pharmacokinet Biopharm; 1987 Oct; 15(5):473-96. PubMed ID: 3694493
[TBL] [Abstract][Full Text] [Related]
13. An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.
Pang KS; Terrell JA; Nelson SD; Feuer KF; Clements MJ; Endrenyi L
J Pharmacokinet Biopharm; 1986 Apr; 14(2):107-30. PubMed ID: 3746635
[TBL] [Abstract][Full Text] [Related]
14. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
Ratna S; Chiba M; Bandyopadhyay L; Pang KS
Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
[TBL] [Abstract][Full Text] [Related]
15. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation.
Fayz S; Cherry WF; Dawson JR; Mulder GJ; Pang KS
Drug Metab Dispos; 1984; 12(3):323-9. PubMed ID: 6145559
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic method for the quantitation of salicylamide and its metabolites in biological fluids.
Xu X; Pang KS
J Chromatogr; 1987 Sep; 420(2):313-27. PubMed ID: 3693503
[TBL] [Abstract][Full Text] [Related]
18. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
19. Some quantitative evaluation of first-pass metabolism of salicylamide in rabbit and rat.
Shibasaki J; Konishi R; Koike M; Imamura A; Sueyasu M
J Pharmacobiodyn; 1981 Feb; 4(2):91-100. PubMed ID: 7277202
[TBL] [Abstract][Full Text] [Related]
20. FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide -- a metabolite of salicylamide.
Jadrijević-Mladar Takac M; Vikić Topić D; Govorcinović T
Acta Pharm; 2004 Sep; 54(3):163-76. PubMed ID: 15610614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
